A-51 as A Natural Calcium Channel Blocker: An Integrative Study Targeting Hypertension

Authors

  • Rohatoy Sayidaliyeva Andijan State University, Andijan region, Uzbekistan
  • Shokhida Kadirova National University of Uzbekistan, Toshkent, Uzbekistan
  • Anvar Zaynabiddinov Andijan State University, Andijan region, Uzbekistan
  • Izzatullo Abdullaev A. S. Sadykov Institute of Bioorganic Chemistry of the Science Academy of Uzbekistan, Plant Cytoprotectors Laboratory and Pharamacology, Tashkent, Uzbekistan
  • Lazizbek Makhmudov A. S. Sadykov Institute of Bioorganic Chemistry of the Science Academy of Uzbekistan, Plant Cytoprotectors Laboratory and Pharamacology, Tashkent, Uzbekistan
  • Ulugbek Gayibov A. S. Sadykov Institute of Bioorganic Chemistry of the Science Academy of Uzbekistan, Plant Cytoprotectors Laboratory and Pharamacology, Tashkent, Uzbekistan
  • Mukhbbat Yuldasheva National University of Uzbekistan, Toshkent, Uzbekistan
  • Madina Kholmirzayeva Andijan State University, Andijan region, Uzbekistan
  • Rakhmatilla Rakhimov Tashkent State Transport University, Tashkent, Uzbekistan
  • Azizbek Mutalibov Andijan State University, Andijan region, Uzbekistan
  • Hayotbek Karimjonov Andijan State University, Andijan region, Uzbekistan

DOI:

https://doi.org/10.48048/tis.2025.10760

Keywords:

A-51, Vasorelaxation, Blood pressure, Calcium channels, Nitric oxide, Molecular docking

Abstract

This study investigates the vasorelaxant and antihypertensive potential of compound A-51 through an integrative approach involving in vitro, in vivo, and molecular docking analyses. A-51 induced concentration-dependent relaxation of rat aortic rings pre-contracted with 50 mM KCl, achieving 76.0% ± 2.7% relaxation at 60 μM, with an IC₅₀ of 31.54 μM. In phenylephrine (1 μM)-induced contractions, the effect was even stronger, with 80.0% ± 1.7% inhibition observed at 45 μM. Endothelium removal reduced the relaxant response by 25.0% ± 2.4%, indicating partial dependence on endothelial nitric oxide pathways. In vivo, A-51 administered at 25 mg/kg significantly lowered systolic blood pressure from 98.0 ± 8.9 mmHg to 84.3 ± 8.3 mmHg and diastolic pressure from 74.8 ± 7.3 mmHg to 58.0 ± 5.6 mmHg within 2 h. In adrenaline-induced hypertensive rats, A-51 at 50 mg/kg reduced systolic pressure from 160.3 ± 11.6 mmHg to 93.3 ± 9.2 mmHg within 3 h, demonstrating its antihypertensive efficacy under pathophysiological conditions. Molecular docking studies revealed strong binding affinities between A-51 and calcium-regulating proteins, including Ca²⁺-ATPase and the Na⁺/Ca²⁺ exchanger, with binding energies of −6.6 kcal/mol, supporting its role as a calcium modulator. Together, these findings highlight A-51’s multi-target mechanism of action involving vascular smooth muscle relaxation and endothelial support. Its notable efficacy, combined with natural origin, positions A-51 as a promising candidate for further development as a novel antihypertensive agent.

HIGHLIGHTS

  • A51 was investigated for antihypertensive activity using integrated in vitro, in vivo, and in silico approaches.
  • In vitro studies assessed A51’s effects on L-type and receptor-operated Ca²⁺ channels in isolated rat aortic rings.
  • In vivo evaluation was conducted in an adrenaline-induced hypertension model in male Wistar rats.
  • In silico molecular docking targeted key aortic ion channels involved in calcium regulation.
  • The study aimed to elucidate the calcium-modulating mechanisms underlying A51’s vascular effects.

GRAPHICAL ABSTRACT

Downloads

Download data is not yet available.

References

MD Cesare, P Perel, S Taylor, C Kabudula, H Bixby, TA Gaziano, DV McGhie, J Mwangi, B Pervan, J Narula, D Pineiro and FJ Pinto. The heart of the world. Glob Heart 2024; 19(1), 11.

IZOGL Abdullaev, UG Gayibov, SZ Omonturdiev, SF Azamjonovna, SN Gayibova and TF Aripov. Molecular pathways in cardiovascular disease under hypoxia: Mechanisms, biomarkers, and therapeutic targets. The Journal of Biomedical Research 2025; 39(3), 254-269.

CJ Hutchings, P Colussi and TG Clark. Ion channels as therapeutic antibody targets. MAbs 2019; 11(2), 265-296.

AA Abdullaev, DR Inamjanov and DS Abduazimova. Silybum marianum’s impact on physiological alterations and oxidative stress in diabetic rats. Biomedical and Pharmacology Journal 2024; 17(2), 1291-1300.

BK Joseph, KM Thakali, CL Moore and SW Rhee. Ion channel remodeling in vascular smooth muscle during hypertension: Implications for novel therapeutic approaches. Pharmacological Research 2013; 70(1), 126-138.

O Gaibullayeva, A Islomov, D Abdugafurova, B Elmurodov, B Mirsalixov, L Mahmudov, I Adullaev, K Baratov, S Omonturdiev and S Sa’dullayeva. Inula helenium L. root extract in sunflower oil: Determination of its content of water-soluble vitamins and immunity-promoting effect. Biomedical and Pharmacology Journal 2024; 17(4), 2729-2737.

AQQ Azimova, AX Islomov, SA Maulyanov, DG Abdugafurova, LU Mahmudov, IGO Abdullaev, AS Ishmuratova, SQQ Siddikova and IR Askarov. Determination of vitamins and pharmacological properties of Vitis vinifera L. plant fruit part (mixed varieties) syrup-honey. Biomedical and Pharmacology Journal 2024; 17(4), 2779-2786.

AV Mahmudov, OS Abduraimov, SB Erdonov, UG Gayibov and YL Izotova. Bioecological features of nigella sativa L. in different conditions of Uzbekistan. Plant Science Today 2022; 9(2), 421-426.

OS Zoirovich, AI Ugli, ID Raxmatillayevich, ML Umarjonovich, ZM Ravshanovna, GS Narimanovna, GU Gapparjanovich and AT Fatikhovich. The effect of ajuga turkestanica on the rat aortic smooth muscle ion channels. Biomedical and Pharmacology Journal 2024; 17(2), 1213-1222.

D Inomjonov, I Abdullaev, S Omonturdiev, A Abdullaev, L Maxmudov, M Zaripova, M Abdullayeva, D Abduazimova, S Menglieva, S Gayibova, M Sadbarxon, U Gayibov and T Aripov. In vitro and in vivo studies of crategus and inula helenium extracts: Their effects on rat blood pressure. Trends in Sciences 2025; 22(3), 9158.

A Abdullaev, I Abdullaev, A Bogbekov, U Gayibov, S Omonturdiev, S Gayibova, M Turahodjayev, K Ruziboev and T Aripov. Antioxidant potential of rhodiola heterodonta extract: Activation of nrf2 pathway via integrative in vivo and in silico studies. Trends in Sciences 2025; 22(5), 9521.

HM Berman, J Westbrook, Z Feng, G Gilliland, TN Bhat, H Weissig, IN Shindyalov and PE Bourne. The protein data bank. Nucleic Acids Research 2000; 28(1), 235-242.

H Zohny, J McMillan and M King. Ethics of generative AI. Journal of Medical Ethics 2023; 49(2), 79-80.

M Iman, A Saadabadi and A Davood. Molecular docking analysis and molecular dynamics simulation study of ameltolide analogous as a sodium channel blocker. Turkish Journal of Chemistry 2015; 39(2), 306-316.

J Palacios, D Asuncion-Alvarez, D Aravenaet, M Chiong, MA Catalan, C Parra, F Cifuentes and A Paredes. A new oxime synthesized from Senecio nutans SCh. Bip (chachacoma) reduces calcium influx in the vascular contractile response in rat aorta. RSC Advances 2024; 14(14), 9933-9942.

J Striessnig, NJ Ortner and A Pinggera. Pharmacology of L-type calcium channels: Novel drugs for old targets? Current Molecular Pharmacology 2015; 8(2), 110-122.

M Al-Khrasani, DA Karadi, AR Galambos, B Sperlagh and ES Vizi. The pharmacological effects of phenylephrine are indirect, mediated by noradrenaline release from the cytoplasm. Neurochemical Research 2022; 47(11), 3272-3284.

UG Gayibov, SN Gayibova, HM Karimjonov, AA Abdullaev, DS Abduazimova, RN Rakhimov, HS Ruziboev, MA Xolmizayeva, AE Zaynabiddinov and TFA Aripov. Antioxidant and cardioprotective properties of polyphenolic plant extract of Rhus glabra L. Plant Science Today 2024; 11(3), 655-662

TF Aripov and UG Gayibov. Antiradical and antioxidant activity of the preparation “Rutan” from Rhus coriaria L. Journal of Theoretical and Clinical Medicine 2023; 4, 164-170.

AV Mahmudov, OS Abduraimov, SB Erdonov, AL Allamurotov, OT Mamatqosimov, UG Gayibov and L Izotova. Seed productivity of linum usitatissimum L. in different ecological conditions of Uzbekistan. Plant Science Today 2022; 9(4), 1090-1101.

A Sandoo, JJVV Zanten, GS Metsios, D Carroll and GD Kitas. The endothelium and its role in regulating vascular tone. The Open Cardiovascular Medicine Journal2010; 4, 302-312.

PJ Tonge. Drug-target kinetics in drug discovery. ACS Chemical Neuroscience 2018; 9(1), 29-39.

E El-Assri, Y El-Assri, RE Brahimi, ME Fadili, A Baghouz, HA Abuelizz, S Er-Rahmani, A Lahkimi and A Bouia Molecular characterization, chemical profile and biological properties of essential oils from Chamaemelum nobile (L.) flowers of Morocco: In vitro and in silico studies. Frontiers in Chemistry 2025; 13, 1539872.

Y Umidakhon, B Erkin, G Ulugbek, N Bahadir and A Karim. Correction of the mitochondrial NADH oxidase activity, peroxidation and phospholipid metabolism by haplogenin-7-glucoside in hypoxia and ischemia. Trends in Sciences 2022; 19(21), 6260.

UG Gayibov, EJ Komilov, RN Rakhimov, NA Ergashev, NG Abdullajanova, MI Asrorov and TF Aripov. Influence of new polyphenol compound from Euphorbia plant on mitochondrial function. Journal of Microbiology Biotechnology and Food Sciences 2019; 8(4), 1021-1025.

M Zaripova, I Abdullaev, A Bogbekov, U Gayibov, S Omonturdiev, R Makhmudov, N Ergashev, G Jabbarova, S Gayibova and T Aripov. In Vitro and in Silico Studies of Gnaphalium U. Extract: Inhibition of α-amylase and α-glucosidase as a Potential Strategy for Metabolic Syndrome Regulation. Trends in Sciences 2025; 22(8), 10098.

E Capes, R Loaiza and HH Valdivia. Ryanodine receptors. Skeletal Muscle 2011; 1(1), 18.

DK Muratova, NA Ergashev, AV Shkinev, MI Asrarov and UK Kurbanov. Effect of songorine on the activity of ATP-dependent K⁺ channels and the state of megapore in rat liver mitochondria. Eksperimental’naya i Klinicheskaya Farmakologiya 2021; 84(4), 12-15.

MK Pozilov, UG Gayibov, MI Asrarov, NG Abdulladjanova, HS Ruziboev and TF Aripov. Physiological alterations of mitochondria under diabetes condition and its correction by polyphenol gossitan. Journal of Microbiology, Biotechnology and Food Sciences 2022; 12(2), e2224.

AG Vakhobjonovna, KE Jurayevich, AIZ Ogli, EN Azamovich, MR Rasuljonovich and AM Islomovich. Tannins as Modulators in the prevention of mitochondrial dysfunction. Trends in Sciences 2025; 22(8), 10436.

Z Shakiryanova, R Khegay, U Gayibov, A Saparbekova, Z Konarbayeva, A Latif and O Smirnova. Isolation and study of a bioactive extract enriched with anthocyanin from red grape pomace (Cabernet Sauvignon). Agronomy Research 2023; 21(3), 1293-1303.

UG Gayibov, SN Gayibova, MK Pozilov, FS Tuxtaeva, UR Yusupova, GMK Djabbarova, ZA Mamatova, NA Ergashev and TF Aripov. Influence of quercetin and dihydroquercetin on some functional parameters of rat liver mitochondria. Journal of Microbiology, Biotechnology and Food Sciences 2021; 11(1), e2924.

S Sodiqova, S Kadirova, A Zaynabiddinov, I Abdullaev, L Makhmudov, U Gayibov, M Yuldasheva, M Xolmirzayeva, R Rakhimov, A Mutalibov and H Karimjonov. Channelopathy activity of A-41(Propyl ester of gallic acid: Experimental and computational study of antihypertensive activity. Trends in Sciences 2025; 22(9), 10496.

MR Zaripova, SN Gayibova, RR Makhmudov, AA Mamadrahimov, NL Vypova, UG Gayibov, SM Miralimova and TF Aripov. Characterization of Rhodiola heterodonta (Crassulaceae): Phytocomposition, antioxidant and antihyperglycemic activities. Preventive Nutrition and Food Science 2024; 29(2), 135-145.

AR Gutnikova. On the membranotropic action of heavy metal salts and the main ways of its correction. Toxicological Bulletin 2009; 3(96), 21-26.

UG Gayibov, ED Komilov, NA Ergashev, RN Rakhimov, NG Abdullazhanova, MI Asrarov and TF Aripov. Antioxidant and membrane-active properties of 1,4,6-tri-O-galloyl-2,3-valonoyl-β-D-glucose. European Journal of Medicine 2018; 5(1), 3-15.

Downloads

Published

2025-08-01

Most read articles by the same author(s)

<< < 1 2